1. Home
  2. FTK vs VALN Comparison

FTK vs VALN Comparison

Compare FTK & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flotek Industries Inc.

FTK

Flotek Industries Inc.

HOLD

Current Price

$16.88

Market Cap

522.1M

Sector

Industrials

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.57

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTK
VALN
Founded
1985
2012
Country
United States
France
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
522.1M
536.9M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
FTK
VALN
Price
$16.88
$5.57
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$20.00
$15.50
AVG Volume (30 Days)
201.9K
126.2K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
147.06
N/A
EPS
0.84
N/A
Revenue
$136,092,000.00
N/A
Revenue This Year
$13.33
N/A
Revenue Next Year
$16.38
$93.87
P/E Ratio
$20.71
N/A
Revenue Growth
214.53
N/A
52 Week Low
$6.68
$5.15
52 Week High
$20.41
$12.25

Technical Indicators

Market Signals
Indicator
FTK
VALN
Relative Strength Index (RSI) 53.87 28.77
Support Level $15.89 N/A
Resistance Level $17.67 $6.42
Average True Range (ATR) 0.82 0.28
MACD 0.17 0.09
Stochastic Oscillator 69.33 26.77

Price Performance

Historical Comparison
FTK
VALN

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: